Literature DB >> 15821508

Physicochemical metabolic characteristics for calcium oxalate stone formation in patients with gouty diathesis.

Charles Y C Pak1, Orson W Moe, Khashayar Sakhaee, Roy D Peterson, John R Poindexter.   

Abstract

PURPOSE: We determined why calcium oxalate stones instead of uric acid stones form in some patients with gouty diathesis.
MATERIALS AND METHODS: Gouty diathesis was diagnosed from absence of secondary causes of uric acid stones or low urinary pH, and reduced fractional excretion of urate with discriminant score of the relationship between urinary pH and fractional excretion of urate less than 80. From the stone registry 163 patients with gouty diathesis were identified, including 62 with uric acid stones (GD + UA) and 101 patients with calcium oxalate stones (GD + Ca). Metabolic data and 24-hour urinary chemistry study were compared between the 2 groups.
RESULTS: Compared with GD + UA, GD + Ca had significantly greater urinary calcium (196 +/- 96 mg per day vs 162 +/- 82 mg per day, p <0.05) and significantly lower urinary citrate (430 +/- 228 vs 519 +/- 288 mg per day, p <0.05), resulting in higher urinary saturation of calcium oxalate. Both groups had low urinary pH (less than 5.5) and high urinary undissociated uric acid (greater than 100 mg/dl). Urinary calcium post-oral calcium load was significantly higher in GD + Ca than in GD + UA (0.227 vs 0.168 mg/dl glomerular filtrate, p <0.001).
CONCLUSIONS: Calcium oxalate stones may form in some patients with gouty diathesis due to increased urinary excretion of calcium and reduced excretion of citrate. Relative hypercalciuria in GD + Ca may be due to intestinal hyperabsorption of calcium.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15821508     DOI: 10.1097/01.ju.0000154611.64362.66

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  Uric Acid Nephrolithiasis: A Systemic Metabolic Disorder.

Authors:  Michael R Wiederkehr; Orson W Moe
Journal:  Clin Rev Bone Miner Metab       Date:  2011-12

2.  Calcium oxalate stone and gout.

Authors:  Y M Fazil Marickar
Journal:  Urol Res       Date:  2009-09-25

3.  Safety and Efficacy of Benzbromarone and Febuxostat in Hyperuricemia Patients with Chronic Kidney Disease: A Prospective Pilot Study.

Authors:  Haibo Yu; Xinying Liu; Yaxiang Song; Jiafen Cheng; Hui Bao; Ling Qin; Xuan Zhou; Ling Wang; Ai Peng
Journal:  Clin Exp Nephrol       Date:  2018-05-14       Impact factor: 2.801

4.  Influence of serum uric acid levels on prognosis and survival in amyotrophic lateral sclerosis: a meta-analysis.

Authors:  Alon Abraham; Vivian E Drory
Journal:  J Neurol       Date:  2014-04-04       Impact factor: 4.849

5.  Dose-response relationship between higher serum calcium level and higher prevalence of hyperuricemia: A cross-sectional study.

Authors:  Zhichen Liu; Xiang Ding; Jing Wu; Hongyi He; Ziying Wu; Dongxing Xie; Zidan Yang; Yilun Wang; Jian Tian
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

6.  Decreased Associated Risk of Gout in Diabetes Patients with Uric Acid Urolithiasis.

Authors:  Chan Jung Liu; Jin Shang Wu; Ho Shang Huang
Journal:  J Clin Med       Date:  2019-09-25       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.